The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The biodistribution pattern of EVs can be advantageously modified by the presentation of surface ligands, including RVG, to augment the accumulation of EVs in disease sites [33].”
From Engineered Extracellular Vesicles Loaded with MiR-100-5p Antagonist Selectively Target the Lesioned Region to Promote Recovery from Brain Damage (2025) · cites this paper as [33]
In the citing paper
“Previous experiments have shown that the RVG-modified nanoparticles rapidly deliver targeting ligands to the infarct site following ischemic stroke [33, 41].”
From Engineered Extracellular Vesicles Loaded with MiR-100-5p Antagonist Selectively Target the Lesioned Region to Promote Recovery from Brain Damage (2025) · cites this paper as [33]
In the citing paper
“This is consistent with the previous findings that modified RVG-EVs can be used to administer miR-100-5p antagomir to the infarct site through intranasal delivery [33].”
From Engineered Extracellular Vesicles Loaded with MiR-100-5p Antagonist Selectively Target the Lesioned Region to Promote Recovery from Brain Damage (2025) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140
Ha, D., Yang, N., & Nadithe, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.001 · Cited by 1,346
Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4
Benner, E. J., Luciano, D., Jo, R., Abdi, K., Paez-Gonzalez, P., Sheng, H., Warner, D. S., Liu, C., Eroglu, C., & Kuo, C. T. (2013) · Nature · doi:10.1038/nature12069 · Cited by 282
An updated role of microRNA-124 in central nervous system disorders: a review
Sun, Y., Luo, Z.-M., Guo, X.-M., Su, D.-F., & Liu, X. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00193 · Cited by 223
MicroRNA-124 is a subventricular zone neuronal fate determinant
Akerblom, M., Sachdeva, R., Barde, I., Verp, S., Gentner, B., Trono, D., & Jakobsson, J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0558-12.2012 · Cited by 207
Flagged first, then by citations
Research works printed but not linked: 38
- Lackland, 2014, Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association, Stroke, 45, 315, 10.1161/01.str.0000437068.30550.cf · DOI · Paper page
- Liu, 2013, MicroRNAs in cerebral ischemia-induced neurogenesis, J. Neuropathol. Exp. Neurol., 72, 718, 10.1097/NEN.0b013e31829e4963 · DOI
- Dharap, 2009, Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome, J. Cereb. Blood Flow Metab., 29, 675, 10.1038/jcbfm.2008.157 · DOI
- Jeyaseelan, 2008, MicroRNA expression in the blood and brain of rats subjected to transient focal ischemia by middle cerebral artery occlusion, Stroke, 39, 959, 10.1161/STROKEAHA.107.500736 · DOI
- Mishima, 2007, RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS, Brain Res., 1131, 37, 10.1016/j.brainres.2006.11.035 · DOI · Paper page
- Cheng, 2009, miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche, Nat. Neurosci., 12, 399, 10.1038/nn.2294 · DOI · Paper page
- Sun, 2013, MicroRNA-124 protects neurons against apoptosis in cerebral ischemic stroke, CNS Neurosci. Ther., 19, 813, 10.1111/cns.12142 · DOI
- Hamzei Taj, 2016, MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia, Biomaterials, 91, 151, 10.1016/j.biomaterials.2016.03.025 · DOI · Paper page
- Doeppner, 2013, MicroRNA-124 protects against focal cerebral ischemia via mechanisms involving Usp14-dependent REST degradation, Acta Neuropathol., 126, 251, 10.1007/s00401-013-1142-5 · DOI
- Lakhal, 2011, Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers, BioEssays, 33, 737, 10.1002/bies.201100076 · DOI · Paper page
- Xin, 2014, Exosomes/miRNAs as mediating cell-based therapy of stroke, Front. Cell. Neurosci., 8, 377, 10.3389/fncel.2014.00377 · DOI
- Alvarez-Erviti, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
- Yang, 2016, Wnt/β-catenin signaling mediates the seizure-facilitating effect of postischemic reactive astrocytes after pentylenetetrazole-kindling, Glia, 64, 1083, 10.1002/glia.22984 · DOI
- Santos, 2016, miR-124, -128, and -137 orchestrate neural differentiation by acting on overlapping gene sets containing a highly connected transcription factor network, Stem Cells, 34, 220, 10.1002/stem.2204 · DOI · Paper page
- Wang, 2011, Gli3 is required for maintenance and fate specification of cortical progenitors, J. Neurosci., 31, 6440, 10.1523/JNEUROSCI.4892-10.2011 · DOI · Paper page
- Gu, 2005, Suppression of Stat3 promotes neurogenesis in cultured neural stem cells, J. Neurosci. Res., 81, 163, 10.1002/jnr.20561 · DOI
- Uittenbogaard, 2002, Expression of the bHLH transcription factor Tcf12 (ME1) gene is linked to the expansion of precursor cell populations during neurogenesis, Brain Res. Gene Expr. Patterns, 1, 115, 10.1016/S1567-133X(01)00022-9 · DOI
- Cooper-Kuhn, 2002, Impaired adult neurogenesis in mice lacking the transcription factor E2F1, Mol. Cell. Neurosci., 21, 312, 10.1006/mcne.2002.1176 · DOI
- Leker, 2007, Long-lasting regeneration after ischemia in the cerebral cortex, Stroke, 38, 153, 10.1161/01.STR.0000252156.65953.a9 · DOI
- Li, 2010, Focal cerebral ischemia induces a multilineage cytogenic response from adult subventricular zone that is predominantly gliogenic, Glia, 58, 1610, 10.1002/glia.21033 · DOI
- Ouyang, 2013, microRNAs: innovative targets for cerebral ischemia and stroke, Curr. Drug Targets, 14, 90, 10.2174/138945013804806424 · DOI
- Zhao, 2009, A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination, Nat. Struct. Mol. Biol., 16, 365, 10.1038/nsmb.1576 · DOI · Paper page
- Zhao, 2010, MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling, Proc. Natl. Acad. Sci. USA, 107, 1876, 10.1073/pnas.0908750107 · DOI
- Sun, 2011, miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells, Nat. Commun., 2, 529, 10.1038/ncomms1532 · DOI
- Liu, 2010, Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation, Cell Stem Cell, 6, 433, 10.1016/j.stem.2010.02.017 · DOI
- Liu, 2011, MicroRNA profiling in subventricular zone after stroke: MiR-124a regulates proliferation of neural progenitor cells through Notch signaling pathway, PLoS ONE, 6, e23461, 10.1371/journal.pone.0023461 · DOI
- Alvarez-Buylla, 2004, For the long run: maintaining germinal niches in the adult brain, Neuron, 41, 683, 10.1016/S0896-6273(04)00111-4 · DOI
- Skog, 2008, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers, Nat. Cell Biol., 10, 1470, 10.1038/ncb1800 · DOI · Paper page
- Lopez-Verrilli, 2013, Schwann cell-derived exosomes enhance axonal regeneration in the peripheral nervous system, Glia, 61, 1795, 10.1002/glia.22558 · DOI · Paper page
- Yamamoto, 2015, Inflammation-induced endothelial cell-derived extracellular vesicles modulate the cellular status of pericytes, Sci. Rep., 5, 8505, 10.1038/srep08505 · DOI
- Yeo, 2013, Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery, Adv. Drug Deliv. Rev., 65, 336, 10.1016/j.addr.2012.07.001 · DOI
- Xin, 2012, Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth, Stem Cells, 30, 1556, 10.1002/stem.1129 · DOI
- Xin, 2013, MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles, Stem Cells, 31, 2737, 10.1002/stem.1409 · DOI
- Xin, 2013, Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats, J. Cereb. Blood Flow Metab., 33, 1711, 10.1038/jcbfm.2013.152 · DOI
- Huwyler, 1996, Brain drug delivery of small molecules using immunoliposomes, Proc. Natl. Acad. Sci. USA, 93, 14164, 10.1073/pnas.93.24.14164 · DOI
- Chen, 2012, Modern methods for delivery of drugs across the blood-brain barrier, Adv. Drug Deliv. Rev., 64, 640, 10.1016/j.addr.2011.11.010 · DOI
- Haney, 2015, Exosomes as drug delivery vehicles for Parkinson’s disease therapy, J. Control. Release, 207, 18, 10.1016/j.jconrel.2015.03.033 · DOI · Paper page
- Tian, 2014, A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, 35, 2383, 10.1016/j.biomaterials.2013.11.083 · DOI
Cited by
Sorted by citations
Engineering exosomes for targeted drug delivery
Liang, Y., Duan, L., Lu, J., & Xia, J. (2021) · Theranostics · doi:10.7150/thno.52570 · Cited by 1,547
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Advances in therapeutic applications of extracellular vesicles
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8521 · Cited by 1,039
Exosome Processing and Characterization Approaches for Research and Technology Development
Lai, J. J., Chau, Z. L., Chen, S., Hill, J. J., Korpany, K. V., Liang, N., Lin, L., Lin, Y., Liu, J. K., Liu, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202103222 · Cited by 623
Song, Y., Li, Z., He, T., Qu, M., Jiang, L., Li, W., Shi, X., Pan, J., Zhang, L., Wang, Y., et al. (2019) · Theranostics · doi:10.7150/thno.30879 · Cited by 487
Self-citation
Metadata
- Authors
- Yang, J., Zhang, X., Chen, X., Wang, L., & Yang, G.
- Venue
- Molecular Therapy - Nucleic Acids
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 7
- Pages
- 278-287
- ISSN
- 2162-2531
- PMC
- PMC5415550
- Cited by
- 547
- References
- 6
- Language
- en
- Funders
- National Natural Science Foundation of China and Shaanxi Province (31100979 and 2016JM8005, 81371540)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review